Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Including a subject-paced trial may make the PASAT more acceptable for MS patients.
Implications for multiple sclerosis in the era of the Affordable Care Act: an evolving treatment paradigm.
Epstein-barr virus encephalitis: a case report.
Oral BG-12 (dimethyl fumarate) for relapsing-remitting multiple sclerosis: a review of DEFINE and CONFIRM Evaluation of: Gold R, Kappos L, Arnold D, et al. Placebo-controlled phase 3 study of oral BG-12 for relapsing multiple sclerosis. N Engl J Med 2012;
Review of the novelties presented at the 28th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (III).
Immunoregulatory Effects of Interferon-β in Suppression of Th17 cells.
Iron depletion induced by bloodletting and followed by rhEPO administration as a therapeutic strategy in progressive multiple sclerosis: A pilot, open-label study with neurophysiological measurements.
Morphologic features of the binucleated lymphocytes for the assesment of persistent B-cell polyclonal lymphocytosis.
Is TWEAK a Biomarker for Autoimmune/Chronic Inflammatory Diseases?
The endosomal-lysosomal system: from acidification and cargo sorting to neurodegeneration.
The Urine Proteome Profile Is Different in Neuromyelitis Optica Compared to Multiple Sclerosis: A Clinical Proteome Study.
Neuron-macrophage crosstalk in the intestine: a "microglia" perspective.
Optimal detection of infratentorial lesions with a combined dual-echo MRI sequence: "PT2".
Mechanisms of Antioxidant Induction with High-Dose N-Acetylcysteine in Childhood Cerebral Adrenoleukodystrophy.
Reconstruction of single cortical projection neurons reveals primary spine loss in multiple sclerosis.
From genetic associations to functional studies in multiple sclerosis.
[The role of the solar and geomagnetic activity in the etiology of multiple sclerosis: a review of the literature and prospects of research].
Functional correlates of cognitive dysfunction in multiple sclerosis: A multicenter fMRI Study.
IL7Rα Contributes to Experimental Autoimmune Encephalomyelitis through Altered T Cell Responses and Nonhematopoietic Cell Lineages.
GEMSP exerts a myelin-protecting role in the rat optic nerve.
MAPT gene rs1052553 variant is not associated with the risk for multiple sclerosis.
Clinico-electrophysiological profile and predictors of functional outcome in Guillain-Barre syndrome (GBS).
The Challenges, Advantages, and Future of Phenome-Wide Association Studies.
Chronic Acquired Demyelinating Polyneuropathy following Renal Transplantation.
The role of assessment in enhancing the vocational success of people with multiple sclerosis.
Pages
« first
‹ previous
…
577
578
579
580
581
582
583
584
585
…
next ›
last »